Henry Schein sank -3.6% this evening, compared to the S&P 500's day change of -0.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:
-
Henry Schein has logged a -7.3% 52 week change, compared to -7.6% for the S&P 500
-
HSIC has an average analyst rating of hold and is -2.18% away from its mean target price of $84.0 per share
-
Its trailing earnings per share (EPS) is $3.87, which brings its trailing Price to Earnings (P/E) ratio to 21.2. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $5.78 and its forward P/E ratio is 14.2
-
The company has a Price to Book (P/B) ratio of 3.1 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 1.8, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
HSIC has reported YOY quarterly earnings growth of -67.1% and gross profit margins of 0.3%
-
The company's free cash flow for the last fiscal year was $506,000,000.00 and the average free cash flow growth rate is -3.3%
-
Henry Schein's revenues have an average growth rate of 6.1% with operating expenses growing at 5.8%. The company's current operating margins stand at 6.9%